Viewing Study NCT00003634


Ignite Creation Date: 2025-12-25 @ 2:38 AM
Ignite Modification Date: 2025-12-30 @ 12:20 PM
Study NCT ID: NCT00003634
Status: UNKNOWN
Last Update Posted: 2013-11-06
First Post: 1999-11-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy
Sponsor: AltaRex
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module